Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0605
D

Lack of Documented Rationale for Continued PRN Psychotropic Medication Use

Blair, Nebraska Survey Completed on 05-01-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

Facility staff failed to ensure that a clinical rationale was documented for the continued use of a PRN (as needed) antianxiety medication for one resident. The facility's policy requires that PRN psychotropic medication orders be time-limited, with extensions beyond 14 days only permitted if the prescriber documents a clinical rationale, including effectiveness, ongoing diagnosis, indication, and duration. For the resident in question, who had diagnoses including delirium, major depressive disorder, psychosis, unspecified mood disorder, senile degeneration of the brain, and Alzheimer's disease, a PRN order for lorazepam was continued for six months without the required documentation of rationale by the provider. Record reviews showed that the resident had severe cognitive impairment and was receiving antipsychotic and antidepressant medications, but did not display behaviors according to the MDS. The pharmacist recommended continuation of the PRN lorazepam, and the provider agreed, but failed to document the necessary clinical rationale for its continued use. The DON confirmed during interview that no rationale was documented for the ongoing PRN lorazepam order.

An unhandled error has occurred. Reload 🗙